PTPI
Closed
Petros Pharmaceuticals Inc
0.0325
-0.0015 (-4.41%)
Last Update: 01 Jul 2025 21:29:00
Yesterday: 0.034
Day's Range: 0.0325 - 0.0385
Send
sign up or login to leave a comment!
When Written:
0.99
Petros Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing innovative therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, PET-CT01, is a novel, small molecule inhibitor of the enzyme phosphoribosyl pyrophosphate synthetase (PRPS), which is overexpressed in many types of cancer. PET-CT01 has shown promising results in preclinical studies, and the company is currently conducting a Phase 1 clinical trial in patients with advanced solid tumors.
Petros Pharmaceuticals was founded in 2018 and is headquartered in Durham, North Carolina. The company is led by a team of experienced biotech executives and has partnerships with leading academic institutions and research organizations. Petros Pharmaceuticals is backed by top-tier venture capital firms, including Hatteras Venture Partners, 5AM Ventures, and RA Capital Management.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Petros Pharmaceuticals was founded in 2018 and is headquartered in Durham, North Carolina. The company is led by a team of experienced biotech executives and has partnerships with leading academic institutions and research organizations. Petros Pharmaceuticals is backed by top-tier venture capital firms, including Hatteras Venture Partners, 5AM Ventures, and RA Capital Management.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








